Tell me about FIG ipo

The deep research logic is organized as follows: 

Okay, let's tackle the user's question about FIGS' IPO. First, I need to check the provided references and background information. The user is interested in crypto and the Metaverse, but their current question is about an IPO, so I'll focus on FIGS' IPO details.

Looking at the references, Number 1 shows no results for the IPO date, issuer, or exchange. Number 2 mentions FIGS' business as non-scrubs in the textiles industry. Number 4 and 7 discuss the 2021 IPO, including the offering details, revenue growth, and valuation. Number 6 talks about the company's growth from 2017 to 2020. Number 8 and 13 mention recent analyst ratings and financial metrics as of 2025. Number 17 has price targets and analyst opinions. Number 25 and 29 discuss the company's financial results and earnings calls.

The user's profile shows interest in crypto and short-term returns, but the question is about an IPO. I need to provide a concise yet comprehensive answer. Start with the conclusion, then break down the key points: IPO details, financials, market position, risks, and analyst views. Use tables for clarity and include the visualization as per the query. Make sure to cite the references correctly and avoid any unsupported info. Also, keep the language engaging with emojis to match the user's preference for a fun response.

### 🚨 **Conclusion** 🚨
FIGS, Inc. (NYSE: FIGS) is a healthcare apparel company that went public in **May 2021** through an IPO, raising **$584 million** at a valuation of **$2.8 billion**. The company has shown **robust growth** (146% CAGR from 2017-2020) and operates in a **$79 billion global market** for healthcare apparel. However, recent financials (Q1 2025) reveal **marginal profitability** (-0.08% net margin) and **moderate revenue growth** (4.7% YoY). Analysts remain **mixed** on the stock, with price targets ranging from **$3.75 to $5.00**.

---

### 📊 **Key Details** 📊

#### **1. IPO Overview**
| Metric | Details |
|-----------------------|-------------------------------------------------------------------------|
| **Ticker** | FIGS (NYSE) |
| **IPO Date** | May 27, 2021 |
| **Price Range** | $16–$19 (final price: $22) |
| **Shares Offered** | 26.4 million (5.9M from existing shareholders) |
| **Valuation** | $2.8 billion (post-IPO) |
| **Proceeds** | $584 million |

#### **2. Financial Performance**
| Metric | 2024 vs. 2023 | 2020 vs. 2019 |
|-----------------------|----------------|----------------|
| **Revenue Growth** | 1.8% YoY | 138% YoY |
| **Net Margin** | -0.08% | 1.8% |
| **ROIC** | 115% (2020) | |

#### **3. Market Position**
- **Market Size**: $79B globally (2021 estimate) .
- **Competitive Edge**: Proprietary fabric tech (FIONx) .
- **Growth Drivers**: U.S. healthcare workers (80% revenue) .

#### **4. Risks**
- **Tariffs**: 2024 gross margin decline (150 bps YoY) .
- **Competition**: Generic apparel substitutes .
- **Valuation**: High P/E (583x) vs. peers .

---

### 📊 **Analyst Take** 📊
| Analyst Firm | Rating | Price Target | Key Concerns |
|-----------------------|--------------|---------------|----------------------------------------|
| Morgan Stanley | Equal-Weight | $4.25 | Margin pressures, tariff risks |
| Telsey Advisory | Market Perform | $5.00 | High debt, limited visibility |
| Goldman Sachs | Sell | $3.75 | Uncertain growth trajectory |

---

### 📊 **Why It Matters** 📊
- **For Retail Investors**: FIGS was the **first IPO** on Robinhood’s platform (2021) .
- **For Healthcare Workers**: Dominates **scrubwear** market with 14% U.S. share .
- **For Growth Investors**: High TAM ($79B) but **execution risks** (tariffs, competition).

---

### 📊 **Final Thoughts** 📊
FIGS is a **niche player** in a growing market but faces **short-term profitability challenges**. While the **$3.75–$5.00 price target range** suggests upside potential, **risk-averse investors** may want to wait for clearer margin stabilization.